nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.274	1	CbGaD
Bopindolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.191	0.58	CrCrCtD
Bopindolol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.138	0.42	CrCrCtD
Bopindolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0765	0.2	CbGbCtD
Bopindolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0753	0.197	CbGbCtD
Bopindolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0579	0.152	CbGbCtD
Bopindolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0579	0.152	CbGbCtD
Bopindolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0571	0.15	CbGbCtD
Bopindolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0571	0.15	CbGbCtD
Bopindolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000462	0.158	CrCbGaD
Bopindolol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.000393	0.134	CrCbGaD
Bopindolol—Carvedilol—VEGFA—chronic obstructive pulmonary disease	0.00033	0.113	CrCbGaD
Bopindolol—Mebendazole—CYP1A1—chronic obstructive pulmonary disease	0.000323	0.11	CrCbGaD
Bopindolol—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.0003	0.102	CrCbGaD
Bopindolol—Carvedilol—ADRB2—chronic obstructive pulmonary disease	0.000186	0.0633	CrCbGaD
Bopindolol—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.0582	CrCbGaD
Bopindolol—Carvedilol—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.0543	CrCbGaD
Bopindolol—Carvedilol—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.0524	CrCbGaD
Bopindolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000141	0.0482	CrCbGaD
Bopindolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.0413	CrCbGaD
Bopindolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.0398	CrCbGaD
Bopindolol—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000115	0.00991	CbGpPWpGaD
Bopindolol—ADRB3—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000107	0.00921	CbGpPWpGaD
Bopindolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.0001	0.00858	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	9.52e-05	0.00817	CbGpPWpGaD
Bopindolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	9.26e-05	0.00795	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.15e-05	0.007	CbGpPWpGaD
Bopindolol—Ketoprofen—ALB—chronic obstructive pulmonary disease	7.79e-05	0.0265	CrCbGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	7.64e-05	0.00656	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	7.16e-05	0.00614	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	7.09e-05	0.00609	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	6.46e-05	0.00555	CbGpPWpGaD
Bopindolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	6.37e-05	0.00547	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	6.24e-05	0.00535	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.21e-05	0.00533	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	6.08e-05	0.00522	CbGpPWpGaD
Bopindolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	6.05e-05	0.00519	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	5.97e-05	0.00513	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	5.82e-05	0.005	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	5.65e-05	0.00485	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	5.53e-05	0.00474	CbGpPWpGaD
Bopindolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	5.5e-05	0.00472	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	5.4e-05	0.00464	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.11e-05	0.00439	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.09e-05	0.00437	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.84e-05	0.00415	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.73e-05	0.00406	CbGpPWpGaD
Bopindolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.67e-05	0.00401	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.63e-05	0.00397	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.63e-05	0.00397	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.57e-05	0.00392	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.48e-05	0.00384	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	4.45e-05	0.00382	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.35e-05	0.00374	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4e-05	0.00343	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	3.96e-05	0.0034	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.95e-05	0.00339	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.89e-05	0.00334	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.81e-05	0.00327	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.79e-05	0.00325	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.69e-05	0.00316	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.6e-05	0.00309	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.54e-05	0.00304	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.52e-05	0.00303	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.51e-05	0.00301	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.48e-05	0.00299	CbGpPWpGaD
Bopindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.48e-05	0.00299	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.41e-05	0.00292	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.00291	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.24e-05	0.00279	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.19e-05	0.00274	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.08e-05	0.00265	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.04e-05	0.00261	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.04e-05	0.00261	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.02e-05	0.00259	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.98e-05	0.00256	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.95e-05	0.00253	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.95e-05	0.00253	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.9e-05	0.00249	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.9e-05	0.00249	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.89e-05	0.00248	CbGpPWpGaD
Bopindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.77e-05	0.00238	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.00233	CbGpPWpGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.71e-05	0.00233	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.65e-05	0.00228	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.00227	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.61e-05	0.00224	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.59e-05	0.00223	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.59e-05	0.00223	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.58e-05	0.00222	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.53e-05	0.00217	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.47e-05	0.00212	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.47e-05	0.00212	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.45e-05	0.0021	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.37e-05	0.00204	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.37e-05	0.00204	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.35e-05	0.00202	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.35e-05	0.00201	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.34e-05	0.002	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.32e-05	0.00199	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.00199	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.31e-05	0.00198	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.3e-05	0.00197	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.3e-05	0.00197	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.27e-05	0.00195	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.27e-05	0.00195	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.24e-05	0.00193	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.21e-05	0.0019	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.2e-05	0.00189	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.08e-05	0.00179	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.07e-05	0.00177	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.04e-05	0.00175	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.02e-05	0.00173	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2e-05	0.00172	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.99e-05	0.00171	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.99e-05	0.00171	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.98e-05	0.0017	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.97e-05	0.00169	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.89e-05	0.00162	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.88e-05	0.00162	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.88e-05	0.00161	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.85e-05	0.00159	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.00158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.00157	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.81e-05	0.00155	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.00155	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.79e-05	0.00154	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.00153	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.77e-05	0.00152	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.76e-05	0.00151	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.75e-05	0.0015	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.74e-05	0.00149	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.73e-05	0.00148	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.72e-05	0.00148	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.7e-05	0.00146	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.64e-05	0.00141	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.00134	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.49e-05	0.00128	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.00126	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.00126	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.00123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.4e-05	0.0012	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.0012	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.0012	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.39e-05	0.00119	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.38e-05	0.00118	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.38e-05	0.00118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.36e-05	0.00116	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.33e-05	0.00114	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.33e-05	0.00114	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.31e-05	0.00112	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.28e-05	0.0011	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	0.0011	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.25e-05	0.00107	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.19e-05	0.00102	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.18e-05	0.00101	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.17e-05	0.001	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.001	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.14e-05	0.00098	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.000974	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.12e-05	0.000959	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.12e-05	0.000959	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000959	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.09e-05	0.000938	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000938	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.07e-05	0.000917	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000917	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000913	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.00091	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000906	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.00089	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.03e-05	0.000881	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.02e-05	0.000877	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000871	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.99e-06	0.000858	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.77e-06	0.000839	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.65e-06	0.000829	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.59e-06	0.000823	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.54e-06	0.000819	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.27e-06	0.000796	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.23e-06	0.000792	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.07e-06	0.000779	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.87e-06	0.000762	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.8e-06	0.000755	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.58e-06	0.000737	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.17e-06	0.000701	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.99e-06	0.000686	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.92e-06	0.00068	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.86e-06	0.000675	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.81e-06	0.000671	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.59e-06	0.000652	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.43e-06	0.000638	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.26e-06	0.000624	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.19e-06	0.000618	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.15e-06	0.000614	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.06e-06	0.000606	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.01e-06	0.000602	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.88e-06	0.000591	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.73e-06	0.000578	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.7e-06	0.000575	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.43e-06	0.000552	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.4e-06	0.000549	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.31e-06	0.000542	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.26e-06	0.000538	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.17e-06	0.00053	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.13e-06	0.000526	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.04e-06	0.000518	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.99e-06	0.000514	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.73e-06	0.000492	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.7e-06	0.00049	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.69e-06	0.000489	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.61e-06	0.000481	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.57e-06	0.000478	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.48e-06	0.000471	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.48e-06	0.00047	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.44e-06	0.000467	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.42e-06	0.000466	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.36e-06	0.00046	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.26e-06	0.000451	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.24e-06	0.00045	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.16e-06	0.000443	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.09e-06	0.000437	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.02e-06	0.000431	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.98e-06	0.000428	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.87e-06	0.000418	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.79e-06	0.000411	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.63e-06	0.000398	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.25e-06	0.000365	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.25e-06	0.000365	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.19e-06	0.00036	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.17e-06	0.000358	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.1e-06	0.000352	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.04e-06	0.000347	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.01e-06	0.000344	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4e-06	0.000343	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.91e-06	0.000336	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.84e-06	0.00033	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.82e-06	0.000328	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.82e-06	0.000328	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.73e-06	0.00032	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.65e-06	0.000313	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.5e-06	0.0003	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.45e-06	0.000296	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.38e-06	0.000291	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.31e-06	0.000284	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.24e-06	0.000278	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.22e-06	0.000276	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.2e-06	0.000275	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.17e-06	0.000272	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.15e-06	0.00027	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.11e-06	0.000267	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.08e-06	0.000264	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.06e-06	0.000263	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.99e-06	0.000257	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.93e-06	0.000251	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.75e-06	0.000236	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.69e-06	0.000231	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.63e-06	0.000226	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.61e-06	0.000224	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.52e-06	0.000217	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.47e-06	0.000212	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.47e-06	0.000212	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.42e-06	0.000208	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.41e-06	0.000207	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.39e-06	0.000205	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.37e-06	0.000203	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.08e-06	0.000178	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.03e-06	0.000174	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.99e-06	0.000171	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.9e-06	0.000163	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.86e-06	0.00016	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.82e-06	0.000156	CbGpPWpGaD
